= Camlin Fine Sciences Date: 10/08/2016 To, BSE Limited, 25, P. J. Towers, Dalal Street, Mumbai - 400 001 Ref: Company Scrip Code: 532834 To, The Manager, Listing Department, National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400051 Ref: Symbol: CAMLINFINE | | Series: EQ Sub: Unaudited Financial Results for the quarter ended 30" June, 2016 Dear Sir/Madam, The Board of Directors of the Company at its meeting held today ie., Wednesday, 10" August, 2016 has inter-alia approved the enclosed un-audited financial results for the quarter ended 30" June, 2015. Kindly take the above information on records. Thanking You, Encl. a/a. Thanking You, For Camlin Fine Sciences Limite Rahul D. Sawale Group Company Secretary Aegstered Ofee: 9 Chinn Sener 1-12 ICE Opp SEEPZ, Cen Rad Arter as Mumba 4003 CIN: L74100MH1993PLCO75361 | ISO 22000 Certified Company {+91 22 6700 1000 B 451222032 4404 A corporate@camlinfs.com Cae) wwrw.camlints.com@ 0 3 9 SF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2016 B gSt quiero g $24 STANDALONE TONSOUDATED iran oe. Tas Torte Gaba re g 25 socme | smane [ mcs | simoans | Saacane | siovane [ sonore [saan a8 Traacited) | TAuditedy” | Weaudnea) | (Audited) | (Unaudined)| (Audited | (Unaudited) | Audie fc ees Samar] ep see, ase eee] — mace ge eee ae | es| awe| toom| “seo| exss| 37a] tama Pe ees pee ee nase] wm! sree] somces| asec sen | mim) aan BE Sic omeretoss ee | ame | se |e sun| Corea wem| mown | a 3 = eaten el eel scanmst|| canes |Ptaite| Mermer| asmete|Pasie|? agen s 3% 2 | bependitare 2 88 Sette eat sma] con] races] soon| res| rae| rsam| ran B35 Wetenecueee San] ‘en “aers| “aastoo|“as|era|aree| as 8 3 Jc) Changes in inventories of finished goods, work-in- (41.67) (1.25857) (1,803.11) (2,572.20)] (1,059.42)} (1,511.41)}—_(2,980.32)} (4,716.09)} , Oe Enea g a8 cat snail zam|| dvesuli gees | (Uneen| asen| © aaai| |) sadn RN Lace aie nade eal cao See oeage | Rcaerdl ph aateee|(1 genta|! varie’ “aneae || aimee 58 Robe peas ea) wee | men | aamer| yes] camot| smas| seuss] asamuo 33 Pies need arde tor tins | siese| aneae| seca] sasze| soatere| sane] aan HE | fPastomnatcre tow oneinam tne | sani] isor| ism] san] ror] 2am] aso] amo g MEME eects nie | abe | elf ell, aesl Meee) asks | oy cea ZF |S frctromantmy anand amecats | avaten| reso] aane| oats] asm] assim] zanizs] rx ; 8 aaa ee Bb Vo leeeme en] mal sos) rmm| mol ema] cas © PLS Rema cottetterebeptiatteen | ape] ase] sai] sms] mst| aon| ose] Seas oes | Repepcal ca peat} : 2 | asazs : : i “73 ee oa erepeee een sou | ramse| ecsa| sense| wvess| aainm| oer] sane fue 10 [Tex expenses seu) 2134s] 27530] sas] russ | us| aos] ratot Be a ent lacy adroit 25| ee| Sex| ape) seas] suse] tomae| son Be cerca mc areroneen : AS aes (aie) DS eee & | ts fNerront vote period a3 cxiss| —smss|—sanca| zsreiv| seas] saesa| ram] seam Oo 2 [aici : Ales) Belle rl Sete (ie haces tae : dealt All sk el tS 3 Be Ve Neen ctrsteoy sare css] sn] stcsa| asm] Sones] ose] rzmse| ssa 3 race Value Re:/- pr share i A scalars chy : [Mt eres 28 Pr ees 5 ews oy: ac Sst pres anni i 18 fuming eS EPS) ef ot Seach re sae ete Oe Aen ieee | 2 ad iio &2 a Notes to standalone financial results fr the quarter ended June 30, 2016 i 1 The above unaudited financial resulls were reviewed by the Audit Committee and have been considered and approved by the Board of Directors atts meeting held on August 10,206. a 2 The statutory auditors have caried out Kmited review ofthe above financial results forthe quarter ended June 30, 2016 43 Other expenses includes rebate on export sales atnounting to Rs, 1505 lakh pertaining to th period from January 1, 2015 to December 31,2015 0001 009 2 16+ $y 44 During the las financial year, the insurance claim relating to the fire which occurred in financial year 13-14 was settled by the insurance company. Based on the settlement ‘esceptional tem includes a charge of Rs5473 lakh which was rcordes during that year P91 #90u90 Buy ue 5 On April 15,2016, the Company has incorporated a subsidiary inthe fre trade zone of China namely, CPS International Tracing (Shanghai subscribed towards share capital till June 30,2016, Lid. No amounts have been, 9 Zz 8 g = 8 6 On July 5, 2016, Company has issued and allotted 65,19,500 equity shares of Re. 1 each ata premium of RS84.40 per equity share aggregating to Rs 5.56765 lakh pursuant to (Qualified Institutions Placement under SEBI (ICDR) Regulations, 2009 (as amended), 7 Company's operations constitute a single business sogment busines in Fine Chemicals ‘Quarter Ended fork CERT Ze 6+ Geographical segment disclosure Bones | a10xane | s006a05 | 31.03.2016 (Ceauelited) | (Auditody* | (Unaudited) | (Audited) [Revenues within India 32 is0om 22714 Bas. Revenues outside India 7391 soss.7a] 7.80695] 33,214.80] [rot Taseese] TOs] TOI Ter 15 The Figures forthe quarter ended Nasch 31, 20Tb are he balancing figures Delween the audited figures in respect o the fll financial year ended March 3, 2016 and the ‘unaudited published year to date Figures up to the third quarter ended December 31,2015, which were subject to limited review. Auredwo payne 0907 OSI “RIpU| “£60 OOF FequINHY seg LeypUy ‘PeoY feNUDD “Z4a3S‘ddO “T3DIM ZI 9 On May 4, 2016,CFS Antioxidants De Mexico S.A.cle CV. Mexico, wholly owned subsidiary of the company has acquired 65% equity slake in Dresen Quimica S.A.P.deCV., ‘Mexico and its slsidiaries. 10 Figures for previous periods have been regrouped / rearranged wherever necessary. [Notes to consolidated financial results fr the quarter ended June 30, 2016 1 The note nos. Ito 5 and 10to standalone results should also be considered as notes to consolidated resus 2 Consolidated Gross sales/Income from operation is net of Sales/ Purchase between company and its subsidiary companies. 3 On May 4, 2016,CFS Antioxidantes De Mexico S.A.de C-V. Mexico, wholly owned subsidiary ofthe company has acquired 65% equity stake in Dresen Quimica S.A.PLde CL. Mexico and its subsidiaries, Results of these subsidiaries have been consolidated inthe curent quarter, hence the corresponding figures of previous quarter and corresponding «quarter of last yoar are not comparable. wor'syuywe@areiodios paw 4 The Company's operations constitute a single business segment business in Fine Chemicals, oan om Place: Mumbai Date: August 10, 2016 Ashish S, Dandekar Managing Ditector woos ulpurery= Camlin Fine Sciences Extract of Statement of Standalone & Consolidated Unaudited Financial Results For the Quarter Ended June 30, 2016 aa ne a sisi ee ee Te a a ae i aera core is ca re ae aa | mane gi etme ee Se ee ee oi739| suns] 257529| 13065] 19032 3.0237 Blase are « fener ‘The above information isan extract of the detailed format of unaudited results for the quarter ended June 30,2016 filed with the Stock Exchanges under Regulation 33 of the SEBI (isting Obligations and Disclosure Requirements) Regulations, 2015. The full format of the audited results for the quarter enced June 30, 2016 are available on the Company's websites, www.camlinfs.com and the Stock Exchange websites i, ‘www. bseindia.com and www.nseindia.com Place: Mumbai Date: August 10,2016 Q Registered Offic: FOR CAMLIN FINE SCIENCES LIMITED Ashish S. Dandekar ‘Managing Director ‘Camlin Fine Sciences Led F/I-I2, WICEL, Opp. SEEPZ, Central Road, Andheri East, Mumbai 400 093, India. CIN:L74100MH1993PLCO75361 | ISO 22000 Certified Company © +31 22.6700 1000 B sinew 1@camiinfs.com TD ewmcamiinfcom. K. KHARE & Co. CHARTERED ACCOUNTANTS. +91 022 22000607/7818/6960 +91 022 66315835/35 F +91 022 2200 3476 E info @bkknareco.com 7061708, Sharda Chambers New Marine nes, Mumbai - 400 020, India Limited Review Report ‘The Board of Directors Camlin Fine Sciences Limited We have reviewed the accompanying statement of unaudited standalone financial results of Camilin Fine Sciences Limited for the quarter ended June 30, 2016 (“the Statement’). This Statement is the responsibilty of the Company's management and has been approved by the Board of Directors. Our responsibility is to issue a report on the standalone results for the quarter ended June 30, 2016 based on our review. We conducted our review in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement of unaudited financial results prepared in accordance with the applicable accounting standards specified under Section 133 of the Companies Act, 2013 read with rule 7 of the Companies (Accounts) Rules, 2014 (as amended) and other recognised accounting practices and policies has not disclosed the information required to be disclosed in terms of “Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to ‘be disclosed, or that it contains any material misstatement. We draw attention to the Company's investment of Rs. 56.01 lakhs in and loans of Rs 165.80 lakhs given to its subsidiary company recoverability of which is based on successful implementation of ‘management's future plans in respect of the subsidiary. Our conclusion is not modified in respect of this matter. For B. K. Khare & Co. Chartered Accountants Firm Registration No. 105102W Soak tas Partner Membership No. 105731 Mumbai, August 10, 2016 Pune Bengelura New Delhi T--91 020 6060100516/7/8/9 +91 80 41105357 T491 011 4905 7628 +91 020 25666852/32926341 bkkbengaluru@ bkkhareco.com E bkkdelhi@bkérareco.com E bikkpune @bikkhareco.com 101, Money Chambers, A-4, Westend, Hotel Swaroop, 4th Flor, | tat Foor, #6 K. H. Road, Rao Tula Ram Marg, Lane No.10, Prabhat Reed, ‘Shanthinagar, New Dethi- 110021 Erandwane, Pune - 411 004, India Bengaluru - 560027, India IndiaK. Kare & Co. CHARTERED ACCOUNTANTS +9 a22 22000607/781816960 +01 022 6315828/96 +91 02222002476 Einfo@nkthareco com 706708, Sharda Chambers New Marne ines, Murnba- 400 020, na Limited Review Report ‘The Board of Directors Camlin Fine Sciences Limited 1. We have reviewed the accompanying statement of quarterly unaudited consolidated financial results of Camlin Fine Sciences Limited (“the Company”) and its| subsidiaries (the Company and its subsidiaries are collectively referred to as “the Group) (“the Statement’), for the quarter ended June 30, 2016 attached herewith, being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This Statement the responsibility of the Company's management and has been approved by the Board of Directors. Our responsibility is to issue a report on the consolidated financial results for the quarter ended June 30, 2016, based on our review. 2. We conducted our review in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 3. We did not perform a review on the interim financial statements of 12 subsidiaries included in the quarterly consolidated financial results, whose interim financial statements reflect total assets (before consolidation adjustments) of Rs 29,027.63 lakhs as at June 30, 2016 as well as total revenue (before consolidation adjustments) of Rs 7,964.55 lakhs for the quarter ended June 30, 2016. The consolidated financial results of the Group also include the Group's share of net profit of Rs Nil for the quarter ended June 30, 2016 in respect of 2 of its associates, whose interim financial statements were not reviewed by us. Bengaluru New Delhi T+ 91 020 60601005/678/9 T +91 80 41105357 +91 011 4905 7628 +91 020 25686932/92926941 E bkkbengaluru@bkkhareco.com E bikkdelni@bkkhareco.com E bkkpune@ bkkhareco.com 101, Money Chambers, A 4, Westend, Hotel Swaroop, 4th Floor, ‘st Floor, #6 K. H. Road, Rao Tula Ram Marg, Lane No.10, Prabhat Road, ‘Shanthinagar, ‘Now Detni- 110021, Erandwane, Pune - 411 004, India Bengaluru - 560027, Inia IndiaB. K. KHare & Co. CHARTERED ACCOUNTANTS OF the entities referred to in para 3, the interim financial statements of and other financial information of > 10 subsidiaries whose interim financial statements reflect total assets (before consolidation adjustments) of Rs 29,021.67 lakhs as at June 30, 2016 as well as total revenue (before consolidation adjustments) of Rs 7,957.13 lakhs for the quarter ended June 30, 2016 have been reviewed by other auditors whose reports have been furnished to us and our opinion on the quarterly consolidated financial results, to the extent they have been derived from such interim financial statements is based solely on the report of such other auditors. > 2 subsidiaries whose interim financial statements reflect total assets (before consolidation adjustments) of Rs 5.96 lakhs as at June 30, 2016 as well as total revenue (before consolidation adjustments) of Rs 7.42 lakhs for the quarter ended June 30, 2016 have not been subjected to a review. The interim financial statements of the 2 associates referred to in para 3 above have also not been subjected to a review. These interim financial statements have been furnished to us by management and our conclusion on the quarterly consolidated financial results, to the extent they have been derived from such interim financial statements is based, solely on the interim financial statements provided to us by management. In our opinion and according to the information and explanations given to us by the management, these interim financial statements are not material to the Group. . ‘These quarterly consolidated financial results include the quarterly financial results of the following entities CFS Europe S:p.A CECL Mauritius Private Limited CFS do Brasil Industria, Comercio, Importacao e Exportacao de Aditivos Alimenticios Ltda. CFS North America LLC Solentus North America Inc. CFS Antioxidantes De Mexico S.A. De. CV. Dresen Quimica $.A.P.l. De CV, Industrias Petrotec de Mexico, S.A. de C.V. Nuvel, S.A.C Britec, S.A. Inovel, SAS. Gienel, 5.A. CES International Trading (Shanghai) Ltd. Fine Lifestyle Brands Limited (associate) Fine Lifestyle Solutions Limited (associate) vrvvyyyvyyyyy TyB. K. KHare & Co. CHARTERED ACCOUNTANTS 6. Based on our review conducted as above, nothing has come to our attention that causes us {o believe that the accompanying Statement of quarterly unaudited consolidated financial results prepared in accordance with the applicable accounting standards specified under Section 133 of the Companies Act, 2013 read with rule 7 of the Companies (Accounts) Rules, 2014 (as amended) and other recognised accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. For B. K. Khare & Co. Chartered Accountants Firm Registration No. 105102W Himanshu Chapsey Partner Membership No. 105731 Mumbai, August 10, 2016